Our Dihexa peptide powder represents the highest quality standard available in the peptides australia market. With a purity level exceeding 99%, this nootropic compound (CAS 1401708-83-5) is manufactured under strict GMP conditions for research applications.
Dihexa (C27H44N4O5) is a modified angiotensin IV analog that has shown potential in various research areas. The white freeze-dried powder maintains excellent stability when stored properly in tightly sealed containers protected from light and moisture.
As a leading peptides australia supplier, we provide comprehensive quality documentation including COA and HPLC analysis. Third-party testing is available upon request to verify purity and composition. Each batch undergoes rigorous quality control before release.
Potential research applications include cognitive enhancement studies, neurological research, and metabolic investigations. The compound has shown interesting properties in preliminary research models.
Our peptides australia facility offers flexible packaging options from 1g samples to bulk 25kg quantities. All materials are handled in controlled environments to ensure product integrity. Custom formulations and private labeling services are available for qualified research institutions.
Please note: This product is for research use only. Not for human consumption or diagnostic use. Proper safety protocols should be followed when handling any research chemicals.